Related Experiment Video
Updated: Jul 13, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Desmopressin for haemostasis in cardiac surgery: when to use?
Shahzad G Raja1, Yaseer Shahbaz
1Department of Cardiac Surgery, Royal Hospital for Sick Children, Glasgow, UK. drrajashahzad@hotmail.com
Abstract:
Bleeding after cardiac surgery increases morbidity and exposes patients to the risks associated with blood transfusion. Desmopressin acetate, a synthetic vasopressin analogue, has been used in patients undergoing cardiac operations to reduce postoperative blood loss and transfusion requirements, although a benefit has not been demonstrated in large randomized controlled trials. Therefore, the routine use of desmopressin in uncomplicated cardiac operations is not recommended. This review article discusses the pharmacology of desmopressin as a haemostatic agent and evaluates available clinical evidence to determine current indications for desmopressin as a haemostatic agent in cardiac surgery.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiopulmonary Resuscitation IV: Pharmacological Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Cardiac Catheterization IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Aneurysm IV: Nursing Management
